Docket Number:28A-941007
Inventor:Chi-Huey Wong, Alice Yu, John Yu, Kuo-I Lin, Wen-Bin Yang
IP Status:US 8,906,380 、TW I386220
Abstract:
Methods are disclosed which are useful in increasing maturation of dendritic cells from CD14+ mononuclear cells, by contact with a composition comprising a fucose-containing glycoprotein fraction from Ganoderma lucidum. The extract can also be used for increasing production of a cytokine or a chemokine in a dendritic cell or CD19+ B cell. In addition, a fucose-containing glycoprotein fraction from Ganoderma lucidum can be administered to a subject identified as needing increased immunoglobulin, cytokine, or chemokine production.
Fields of Application:
- For the treatment of certain immunodeficiency disease, such as common variable immunodeficiency (CVID).
- As an adjuvant for prophylactic vaccine and therapeutic cancer vaccines
- For stimulation and pulsing dendritic cells ex vivo for immunotherapy of cancer.
Advantages when compared to the existing technologies:
The precise function of immune modeling effect of Reishi is stll not clear. By investigating the function of Reishi on purified human dentritic cells and B lymphocytes, we have identified the effects of Reishi on specific cells in immune system. Moreover, we found that the timing of applying Reishi to dentritic cells culture appeared to be important.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
